Therapy Areas: Respiratory
21 March 2019 - - US-based drug developer Forma Therapeutics has appointed Frank D. Lee as chief executive officer, starting on March 27, 2019, the company said.

Lee succeeds Steve Tregay...
21 March 2019 - - French biotechnology company Transgene (Euronext Paris: TNG) (PAR: TNG) has secured a EUR 20m revolving credit facility with Natixis, the French Corporate and Investment bank, the co...
21 March 2019 - - The US Food and Drug Administration approved Tecentriq (atezolizumab), in combination with carboplatin and etoposide (chemotherapy), for the initial (first-line) treatment of ad...
21 March 2019 - - German drugmaker Boehringer Ingelheim has filed for regulatory approval of nintedanib in patients with systemic sclerosis associated interstitial lung disease (SSc-ILD) with the FDA ...
20 March 2019 - - Positive results from a pre-specified sub-analysis of the Phase III DECLARE-TIMI 58 trial showed that Farxiga (dapagliflozin) reduced the relative risk of major adverse cardiovascula...
20 March 2019 - - US-based biotechnology company Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) has completed enrollment in two Phase 2 studies, the company said.

The Phase 2 study of EDP-93...
Related Headlines